Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter.

J M DeCara, A Pollak, S Dubrey, R H Falk

Journal: The American journal of cardiology 2000;86(6):685-8, A8

PMID: 10980226

Abstract

The pure class III agent dofetilide was evaluated to determine its effect on atrial function after cardioversion of atrial fibrillation or flutter. Compared with placebo, dofetilide-treated patients had evidence of better atrial function after cardioversion, indicating that this agent has a positive atrial inotropic effect during the period of postcardioversion atrial stunning.

Address: Boston Medical Center, Massachusetts 02118, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.